Ovensa Announces Collaboration with Tetra Bio-Pharma to Tackle Brain Cancer

Ovensa announced that it has entered into a collaboration agreement with Tetra Bio-Pharma to evaluate TRIOZAN™, a proprietary nanomedicine platform for targeted delivery of cannabinoids to brain tumor cells.

Click here to read more

Previous
Previous

Awake Labs Featured on TVO

Next
Next

Apply to Pitch at the National Impact Challenge: Startup Edition